The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects.
Fiche du document
2009
- doi: 10.1093/hmg/ddp169
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1093/hmg/ddp169
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/19377085
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1460-2083[electronic]
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_3BBDA95027BD5
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Group dynamics Association Groups, Social Type II diabetes Ketosis resistant diabetes Adult onset diabetes Noninsulin-dependent diabetes NIDDM (Diabetes) Stable diabetes Maturity onset diabetes Type 2 diabetes Genealogy--Handbooks, manuals, etc Genealogical research Family trees Genealogy--Sources Genealogy--History Family history (Genealogy) Genealogy--Research Ancestry Descent Pedigrees Genealogy--Methodology Type 1 diabetes Brittle diabetes IDDM (Disease) Ketosis prone diabetes Diabetes mellitus Insulin-dependent diabetes Older persons Older adults Seniors (Older people) Elderly people Old people Senior citizens Aging people Aged Case-control studiesCiter ce document
H. Choquet et al., « The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects. », Serveur académique Lausannois, ID : 10.1093/hmg/ddp169
Métriques
Partage / Export
Résumé
A recent study reported an association between the brain natriuretic peptide (BNP) promoter T-381C polymorphism (rs198389) and protection against type 2 diabetes (T2D). As replication in several studies is mandatory to confirm genetic results, we analyzed the T-381C polymorphism in seven independent case-control cohorts and in 291 T2D-enriched pedigrees totalling 39 557 subjects of European origin. A meta-analysis of the seven case-control studies (n = 39 040) showed a nominal protective effect [odds ratio (OR) = 0.86 (0.79-0.94), P = 0.0006] of the CC genotype on T2D risk, consistent with the previous study. By combining all available data (n = 49 279), we further confirmed a modest contribution of the BNP T-381C polymorphism for protection against T2D [OR = 0.86 (0.80-0.92), P = 1.4 x 10(-5)]. Potential confounders such as gender, age, obesity status or family history were tested in 4335 T2D and 4179 normoglycemic subjects and they had no influence on T2D risk. This study provides further evidence of a modest contribution of the BNP T-381C polymorphism in protection against T2D and illustrates the difficulty of unambiguously proving modest-sized associations even with large sample sizes.